Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Virtus LifeSci Biotech Products ETF BBP
$53.33
-$0.8 (-1.50%)
На 18:01, 12 мая 2023
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
54.72
-
week52low
35.26
-
Revenue
-
P/E TTM
0
-
Beta
0.00000000
-
EPS
0.00000000
-
Last Dividend
0.46900000
-
Next Earnings Date
07 мая 2023 г. в 02:05
Описание компании
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
5 Least-Hurt Biotech ETFs of the Last Week
Zacks Investment Research
15 февр 2023 г. в 14:18
Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days.
Can Health Care Stocks Outperform Again In 2023?
Seeking Alpha
11 янв 2023 г. в 18:09
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
2 Sector ETFs Hovering Around a 52-Week High
Zacks Investment Research
06 дек 2022 г. в 14:18
We all know that Wall Street is shattered this year. Still, two sectors -- Biotech and Aerospace -- have recently hit a 52-week high.
5 Best Areas of Q3 of 2022 & Their Top ETFs
Zacks Investment Research
27 сент 2022 г. в 09:02
These ETF areas won in the third quarter of 2022.
Biotech & Crypto -- Best ETF Areas of Last Week
Zacks Investment Research
08 авг 2022 г. в 15:48
Biotech and cryptocurrency -- two ETF areas outperformed last week.